Tyra biosciences to present at upcoming investor conferences

Carlsbad, calif. , feb. 27, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that company management will participate in the following investor conferences: td cowen's 44th annual healthcare conference, march 4-6th : todd harris, ceo of tyra, will present a company overview on wednesday, march 6, 2024, at 2:10 pm et.
TYRA Ratings Summary
TYRA Quant Ranking